Phathom Pharmaceuticals Inc. Common Stock (PHAT)

Stock · NASDAQ · Health Care

$9.18as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$11.38

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

PHAT
Phathom Pharmaceuticals Inc. Common Stock
$9.18
▲ 2.68%
Market cap $726.49MP/E —
DRUG
Bright Minds Biosciences Inc. Common Stock
$72.74
▼ 2.41%
Market cap $723.93MP/E —
$53.99$170
MNPR
Monopar Therapeutics Inc. Common Stock
$112.17
▼ 1.55%
Market cap $747.88MP/E —
$32.77$124.82
CTMX
CytomX Therapeutics Inc. Common Stock
$3.22
▼ 5.99%
Market cap $690.12MP/E —
$1.9$8.21
OCS
Oculis Holding AG Ordinary shares
$12.21
▼ 1.77%
Market cap $689.43MP/E —
$10.52$34.48
PHAR
Pharming Group N.V. ADS each representing 10 ordinary shares
$11.7
▼ 0.68%
Market cap $766.28MP/E 88.15
$0.8338$1.82
ACRS
Aclaris Therapeutics Inc. Common Stock
$6.01
▼ 2.44%
Market cap $772.34MP/E —
$1.74$6.6

Symbol	Market cap	P/E ratio	Price	1D	52-week range
PHAT Phathom Pharmaceuticals Inc. Common Stock	$726.49M	—	$9.18	▲ 2.68%
DRUG Bright Minds Biosciences Inc. Common Stock	$723.93M	—	$72.74	▼ 2.41%	$53.99$170
MNPR Monopar Therapeutics Inc. Common Stock	$747.88M	—	$112.17	▼ 1.55%	$32.77$124.82
CTMX CytomX Therapeutics Inc. Common Stock	$690.12M	—	$3.22	▼ 5.99%	$1.9$8.21
OCS Oculis Holding AG Ordinary shares	$689.43M	—	$12.21	▼ 1.77%	$10.52$34.48
PHAR Pharming Group N.V. ADS each representing 10 ordinary shares	$766.28M	88.15	$11.7	▼ 0.68%	$0.8338$1.82
ACRS Aclaris Therapeutics Inc. Common Stock	$772.34M	—	$6.01	▼ 2.44%	$1.74$6.6

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.